Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel：0512-69998806
    Ministry of Commerce：0512-69998806-8012
    BD：
    East and South China：Ms. Gu 15378638068
    North China, East China：Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department：0512-69998806-8022
    Tumor business：0512-69998806-8058
    Non tumor business：0512-69998806-8026
    Pathogenic microorganism business：0512-69998806-8037
    Integrated Service Platform：0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key model for drug development of ventricular tachycardia

Ventricular tachycardia (VT) refers to a rapid arrhythmia that occurs in the bundle branches, myocardial conduction fibers, and ventricular muscles below the bifurcation of the His bundle. VT can originate in the left and right ventricles, and its frequency often exceeds 100 beats per minute during persistent episodes. It can also deteriorate the hemodynamic state and may transform into ventricular flutter, ventricular fibrillation, leading to sudden cardiac death, requiring active treatment.
Previous:Atrial fibrillation (AF)
Next:Nothing